Clinical Trial Update: Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation. [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating EVT 302 for smoking cessation has completed, assessing its effectiveness in helping participants quit smoking. The sponsor is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• EVT 302

Snippet

Sponsor: Evotec Neurosciences GmbH | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED